← FDA Drug Approvals (Drugs@FDA)
PYRIMETHAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANALUZ · Approved 2020-02-28
Drug application
- FDA Application #
ANDA207127- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PYRIMETHAMINE
- Generic name
- PYRIMETHAMINE
- Active ingredients
- PYRIMETHAMINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SANALUZ
- Manufacturer
- DR.REDDYS LABORATORIES INC
- First approval
- 2020-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown